Charles Peloquin
48PUBLICATIONS
115CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (48)
Sort by Publication Date:
|Mar 06, 2026
Pharmacokinetic and pharmacogenomic predictors of hepatotoxicity in the HIRIF trial for drug-susceptible tuberculosis.Eunsol Yang, Pieter Van Brantegem, Charles A Peloquin
|Feb 23, 2026
Addition of Clofazimine Enhances the Activity of Standard Treatment Regimen in a Mouse Model of Tuberculous Meningitis.Xueyi Chen, Carlos E Ruiz-Gonzalez, Yuderleys Masias-Leon
|Feb 10, 2026
Identifying optimal combination regimens for therapy of Mycobacterium tuberculosis with an algorithmic approach: prospective predictions and validations.Arnold Louie, Michael Neely, Sarah Kim
|Feb 10, 2026
Beyond Rifampin: Evaluating Rifapentine and Rifabutin as Alternative Treatments for TB Meningitis.Xueyi Chen, Carlos E Ruiz-Gonzalez, Yuderleys Masias-Leon
|Jan 16, 2026
Relapse and Emergent Resistance With Novel Short-Course Regimens for Multidrug-Resistant Tuberculosis, United States, 2022-2024.Rina Liang, James C M Brust, Caitlin Reed
|Apr 16, 2025
Impact of Pharmacogenetics on Pharmacokinetics of First-Line Antituberculosis Drugs in the HIRIF Trial.Elizabeth Mackay, Gareth Platt, Charles A Peloquin
Pageof 8
Frequent Collaborators
15 joint publications
Mohammad H Alshaer
10 joint publications
Wael A Alghamdi
7 joint publications
Sarah Kim
6 joint publications
George L Drusano
4 joint publications
Russell R Kempker
4 joint publications
Sanjay K Jain
3 joint publications
Xueyi Chen
2 joint publications
Gustavo E Velásquez
2 joint publications
Awewura Kwara
2 joint publications
Lubbe Wiesner
